Sabra Healthcare REIT, Inc. (SBRA) is a publicly traded Real Estate sector company. As of August 31, 2026, SBRA trades at $20.45 with a market cap of $5.27B and a P/E ratio of 82.04. SBRA moved -0.76% today. Year to date, SBRA is +8.82%; over the trailing twelve months it is +6.73%. Its 52-week range spans $15.60 to $22.77. Analyst consensus is buy with an average price target of $22.64. Rallies surfaces SBRA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for SBRA, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $20.45 |
| Market Cap | $5.27B |
| P/E Ratio | 82.04 |
| EPS | $0.25 |
| Dividend Yield | 0.30% |
| 52-Week High | $22.77 |
| 52-Week Low | $15.60 |
| Volume | 840 |
| Avg Volume | 0 |
| Revenue (TTM) | $859.56M |
| Net Income | $65.23M |
| Gross Margin | 0.00% |
12 analysts cover SBRA: 0 strong buy, 5 buy, 7 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $22.64.